Adage Capital Partners’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-100,000	Closed	-$1.39M	–	843
2024 Q4	$1.39M	Buy	+100,000	New	+$1.39M	﹤0.01%	806
2024 Q3	–	Sell	-200,000	Closed	-$1.86M	–	873
2024 Q2	$1.86M	Buy	+200,000	New	+$1.86M	﹤0.01%	783